Ischemic heart disease Board decisions

The Veteran's heart condition, including coronary artery disease and atrial fibrillation, was granted as secondary to his service-connected acquired psychiatric disorder. The effective date for this grant is February 2, 2025.

The Veteran's lung disease is granted as service-connected due to asbestos exposure during service. The Veteran's coronary artery disease claim is remanded for further evaluation.

The Veteran's heart condition was rated at 100% but reduced to 60%. The reduction was overturned, and the original rating of 100% is restored. SMC based on housebound criteria is also restored.

The Veteran's heart disability is presumed due to herbicide exposure, and service connection for tinnitus has been granted.

The Veteran's claim for service connection for coronary artery disease, claimed as ischemic heart disease, secondary to his service-connected hypertension and atrial fibrillation is granted.,Service connection for the Veteran's back disability cannot be established as it was not incurred in or aggravated by military service.

The Board has determined that the Veteran's claims for service connection for various conditions, including kidney disorder, heart disorder, left shoulder disorder, right shoulder disorder, hearing loss, and bilateral eye disorder (nuclear sclerotic cataracts with vitreous membrane detachment and associated floaters), are remanded due to insufficient evidence. The Board also found that the Veteran's hypertension claim is remanded for further analysis.

The Veteran's TDIU claim for the period from February 27, 2020 is dismissed as moot because he has a combined 100% disability rating and does not meet the criteria for Special Monthly Compensation (SMC) due to being permanently housebound.

The Board dismissed all claims related to the Veteran's service connection and rating for various conditions due to the death of the Appellant.

The Veteran's TDIU rating based on depressive disorder is granted from October 17, 2018 to March 26, 2019. SMC at the housebound rate is also granted prior to March 26, 2019.

The Board denied the Veteran's claims for service connection for ischemic heart disease and a compensable rating for hypertension, finding no current disability or symptoms related to these conditions.

The Veteran's initial evaluation rating for arteriosclerotic heart disease is currently at 10 percent and he believes it does not reflect the severity of his disability. The Board has found that there are conflicting medical opinions regarding the severity of the Veteran's condition, which requires further examination to resolve.

The Board has granted attorney fees based on the past-due benefits awarded in June 2024 for an increased disability rating of 100% for heart disease and hypertension, effective from January 2024.

The Veteran's ischemic heart disease was rated at 60 percent effective December 10, 2019.

The Veteran's claims for service connection for various conditions are dismissed due to untimely filing of the Notice of Disagreement (NOD). The appeal is also dismissed as there was no good cause shown for the late filing.

The Board has determined that there was a pre-decisional duty to assist error and the case is being remanded for further examination and opinion regarding whether the Veteran's service-connected PTSD caused or aggravated his tobacco use, which in turn led to his heart condition.

The Veteran's appeal is remanded for additional development to address service connection and rating issues, including OSA, headaches, heart disability, GERD, right foot achilles disability, and hypertension.

The Veteran's adjustment disorder with mixed anxiety and depressed mood is granted at a 70 percent evaluation, effective November 17, 2022. The rating for chronic kidney disease remains noncompensable.

The Veteran's bilateral ankle strain, right knee strain, OSA, acquired psychiatric disability (depressive disorder and anxiety disorder), and CAD have all been granted service connection.,Service connection has been established for these conditions based on their direct relationship to the Veteran's military service.

The Board has remanded the claims for diabetes mellitus, Type II and related peripheral neuropathies as well as erectile dysfunction and coronary artery disease due to in-service exposure to toxic substances. The AOJ is required to verify whether the USS Suribachi was a brown water ship known to transport Agent Orange and obtain a VA examination to determine if these conditions are related to service.

The Board has remanded the claims for service connection for a heart disorder and skin disorder, as well as an initial rating greater than 0 percent for hypertension from April 3, 2023. The AOJ is instructed to clarify if the cited VA treatment records exist and attempt to obtain them.